[Recent remarkable advances in molecular biology offer the possibility of new findings about the role of alpha(1)-AR subtypes and new therapeutic options for BPH; however, even though alpha(1)-AR antagonists are used as the first-line medical treatment for patients affected by LUTS/BPH, responses to alpha(1)-AR antagonists differ among patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE